Leslie Orne, CEO, Trinity Life Sciences

Leslie Orne is a singular force for change in the life science industry. Her passion for science and her understanding of what it takes to transform scientific discovery into commercially successful, life-changing therapies have enabled her to make data-driven and evidence-based decisions that bring maximum value to Trinity, its clients, and the patients that life science industry seeks to serve. Starting at Trinity more than two decades ago, Leslie has been a leading force in growing the company from a respected boutique consultancy into an industry powerhouse that is the leading provider of go-to-market analytics and AI to pharma companies and continually innovates new products and services that allow its clients to succeed in an industry with many high-profile and costly failures. Leslie’s uncanny ability to cut through hype and clutter and see the real challenges and opportunities in life science commercial operations has made Leslie THE trusted advisor for senior leaders at the most important organizations in the Greater Boston biotech hub. This is reflected in her participation in commercial diligence and strategic decision-making on acquisitions in the space totaling over billions. A consummate team player, Leslie also has played a leading role in establishing a diverse and inclusive culture at Trinity which recognizes that meeting the needs of all patients requires having people from all walks of life at the table where critical decisions are made. She has hired and mentored countless Boston area biotech leaders. For some, Trinity is often a steppingstone to accelerated leadership positions at the top companies in the area, including Biogen, Vertex, Sanofi-Genzyme, Takeda, to name a few. These companies employ Trinity alum in critical roles, and all point to Leslie’s influence in their career development. This influence will continue as these young leaders continue to grow in their roles in the industry.